Avient Corp: Form 10-Q for the period ended Mar 31, 2023
Filed with the SEC on May 3, 2023 and accepted by EDGAR at May 3, 2023, 15:33 ET.
Management's discussion and analysis
As filed, 18,088 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our Business
We are a premier formulator of specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world. Our products include specialty engineered materials, performance fibers, advanced composites, and color and additive systems. We are also a highly specialized developer and manufacturer of performance enhancing additives, liquid colorants and fluoropolymer and silicone colorants. Headquartered in Avon Lake, Ohio, we have manufacturing and warehouse across the globe. We provide value to our customers through our ability to link our knowledge of polymers and formulation technology with our manufacturing and supply chain capabilities to provide value-added solutions to designers, assemblers and processors of plastics. When used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “Avient” and the “Company” mean Avient Corporation and its consolidated subsidiaries.
Highlights and Executive Summary
Trends and Developments
APM Acquisition
On September 1, 2022, the Company completed the acquisition of the DSM Protective Materials business, including the Dyneema® brand, the World's Strongest Fiber™. The ultra-light specialty fiber is used in demanding applications such as ballistic personal protection, marine and sustainable infrastructure, renewable energy, industrial protection and outdoor sports. The acquired business is collectively referred to as Avient Protective Materials and APM. The APM Acquisition will enhance Avient's material offerings of composites and engineered fibers.
Distribution business sale
On November 1, 2022, Avient sold its Distribution business to an affiliate of H.I.G. Capital, (the "Purchaser") for $950.0 million in cash, subject to a customary working capital adjustment. Total proceeds received were $935.5 million, of which $7.3 million was received in the period ended March 31, 2023. The results of the Distribution business are presented as discontinued operations for all periods presented.
Results of Operations — The three months ended March 31, 2023 compared to three months ended March 31, 2022:
(Dollars in millions, except per share data)
| Three Months Ended March 31, 2023 | 2022 | Variances — Favorable (Unfavorable) Change | % Change | |
|---|---|---|---|---|
| Sales | $845.7 | $892.2 | $(46.5) | (5.2)% |
| Cost of sales | 598.1 | 637.8 | 39.7 | 6.2% |
| Gross margin | 247.6 | 254.4 | (6.8) | (2.7)% |
| Selling and administrative expense | 190.5 | 152.2 | (38.3) | (25.2)% |
| Operating income | 57.1 | 102.2 | (45.1) | (44.1)% |
| Interest expense, net | (28.8) | (16.9) | (11.9) | (70.4)% |
| Other income (expense), net | 0.7 | (0.6) | 1.3 | nm |
| Income from continuing operations before income taxes | 29.0 | 84.7 | (55.7) | (65.8)% |
| Income tax expense | (7.7) | (20.0) | 12.3 | 61.5% |
| Net income from continuing operations | 21.3 | 64.7 | (43.4) | (67.1)% |
| (Loss) income from discontinued operations, net of income taxes | (0.9) | 19.8 | (20.7) | nm |
| Net income | 20.4 | 84.5 | (64.1) | (75.9)% |
| Net income attributable to noncontrolling interests | (0.5) | (0.3) | (0.2) | nm |
| Net income attributable to Avient common shareholders | $19.9 | $84.2 | $(64.3) | (76.4)% |
| Earnings (loss) per share attributable to Avient common shareholders - Basic | ||||
| Continuing operations | $0.23 | $0.70 | ||
| Discontinued operations | (0.01) | 0.22 | ||
| Total | $0.22 | $0.92 | ||
| Earnings (loss) per share attributable to Avient common shareholders - Diluted | ||||
| Continuing operations | $0.23 | $0.70 | ||
| Discontinued operations | (0.01) | 0.21 | ||
| Total | $0.22 | $0.91 |
nm - not meaningful
Sales
Sales decreased $46.5 million or 5.2% in the three months ended March 31, 2023 compared to the three months ended March 31, 2022. The acquisition of APM increased sales by 10.8%, which was more than offset by the impacts of lower global demand and customer destocking as well as the unfavorable impact of foreign currency.
Cost of sales
As a percent of sales, cost of sales decreased from 71.5% to 70.7% in the three months ended March 31, 2022 to March 31, 2023, primarily as a result of mix along with raw material deflation, partially offset by higher restructuring charges in the first quarter 2023.
Selling and administrative expense
Selling and administrative expense increased $38.3 million during the three months ended March 31, 2023 compared to the three months ended March 31, 2022, primarily driven by the acquisition of APM along with higher restructuring charges associated with 2023 actions taken in response to lower global demand.
Interest expense, net
Interest expense, net increased $11.9 million in the three months ended March 31, 2023 compared to the three months ended March 31, 2022 related to due to new debt financing associated with the APM Acquisition and the impact of higher interest rates on our variable term debt.
Income taxes
During the three months ended March 31, 2023, the Company’s effective tax rate was 26.6% versus 23.5% for the three months ended March 31, 2022. The income tax rate increase is primarily due to the higher tax expense associated with valuation allowances, and a higher rate effect of foreign withholding tax for the three months ended March 31, 2023 compared to the three months ended March 31, 2022. This increase was partially offset by favorable permanent tax items for the three months ended March 31, 2023 compared to the three months ended March 31, 2022.
SEGMENT INFORMATION
Avient has two reportable segments: (1) Color, Additives and Inks; and (2) Specialty Engineered Materials. As a result of the agreement to divest the Distribution business segment, we have removed Distribution as a separate reportable segment and its results are presented as a discontinued operation. Historical information has been retrospectively adjusted to reflect these changes. Discontinued operations are further discussed in Note 3, Discontinued Operations, to the accompanying condensed consolidated financial statements.
Operating income is the primary measure that is reported to our chief operating decision maker (CODM) for purposes of allocating resources to the segments and assessing their performance. Operating income at the segment level does not include: corporate general and administrative expenses that are not allocated to segments; intersegment sales and profit eliminations; charges related to specific strategic initiatives such as the consolidation of operations; restructuring activities, including employee separation costs resulting from personnel reduction programs, plant closure and phase-in costs; executive separation agreements; share-based compensation costs; asset impairments; environmental remediation costs, along with related gains from insurance recoveries, and other liabilities for facilities no longer owned or closed in prior years; actuarial gains and losses associated with our pension and other post-retirement benefit plans; and certain other items that are not included in the measure of segment profit or loss that is reported to and reviewed by our CODM. These costs are included in Corporate.
Sales and Operating Income — The three months ended March 31, 2023 compared to the three months ended March 31, 2022:
(Dollars in millions)
| Sales: | Three Months Ended March 31, 2023 | 2022 | Variances — Favorable (Unfavorable) Change | % Change |
|---|---|---|---|---|
| Color, Additives and Inks | $537.0 | $649.5 | $(112.5) | (17.3)% |
| Specialty Engineered Materials | 309.7 | 243.1 | 66.6 | 27.4% |
| Corporate | (1.0) | (0.4) | (0.6) | (150.0)% |
| Total Sales | $845.7 | $892.2 | $(46.5) | (5.2)% |
| Operating income: | ||||
| Color, Additives and Inks | $65.6 | $94.5 | $(28.9) | (30.6)% |
| Specialty Engineered Materials | 43.1 | 38.3 | 4.8 | 12.5% |
| Corporate | (51.6) | (30.6) | (21.0) | (68.6)% |
| Total Operating Income | $57.1 | $102.2 | $(45.1) | (44.1)% |
Color, Additives and Inks
Sales decreased $112.5 million or 17.3% in the three months ended March 31, 2023 compared to the three months ended March 31, 2022 primarily driven by global demand and customer destocking and the unfavorable impact of foreign currency.
Operating income decreased $28.9 million in the three months ended March 31, 2023 compared to the three months ended March 31, 2022 driven by lower global demand and customer destocking.
Specialty Engineered Materials
Sales increased $66.6 million or 27.4% in the three months ended March 31, 2023 compared to the three months ended March 31, 2022. The acquisition of APM increased sales by 39.7%, which was partially offset by the impacts of lower global demand and customer destocking.
Operating income increased $4.8 million in the three months ended March 31, 2023 as compared to the three months ended March 31, 2022, as the impact of APM more than offset the aforementioned lower demand and customer destocking.
Corporate
Corporate costs increased $21.0 million or 68.6% in the three months ended March 31, 2023 as compared to the three months ended March 31, 2022 primarily due to higher restructuring charges in the first quarter of 2023.
Liquidity and Capital Resources
Our objective is to finance our business through operating cash flow and an appropriate mix of debt and equity. By laddering the maturity structure, we avoid concentrations of debt maturities, reducing liquidity risk. We may from time to time seek to retire or purchase our outstanding debt with cash and/or exchanges for equity securities, in open market purchases, privately negotiated transactions or otherwise. We may also seek to repurchase our outstanding common shares. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved have been and may continue to be material.
The following table summarizes our liquidity as of March 31, 2023 and December 31, 2022:
(In millions)
| As of March 31, 2023 | As of December 31, 2022 | |
|---|---|---|
| Cash and cash equivalents | $582.7 | $641.1 |
| Revolving credit availability | 226.8 | 246.2 |
| Liquidity | $809.5 | $887.3 |
As of March 31, 2023, approximately 58% of the Company’s cash and cash equivalents resided outside the United States.
Expected sources of cash needed to satisfy cash requirements for 2023 include our cash on hand, cash from operations and available liquidity under our revolving credit facility, if needed. Expected uses of cash for 2023 include interest payments, cash taxes, dividend payments, share repurchases, environmental remediation costs and capital expenditures.
Cash Flows
The following describes the significant components of cash flows from operating, investing and financing activities for the three months ended March 31, 2023 and 2022.
Operating Activities — In the three months ended March 31, 2023, net cash used by operating activities was $22.2 million as compared to net cash provided by operating activities of $18.9 million for the three months ended March 31, 2022, driven primarily by lower earnings.
Investing Activities — Net cash used by investing activities during the three months ended March 31, 2023 of $13.0 million reflects the impact of capital expenditures, offset by proceeds received from the divestiture of the Distribution business.
Net cash used by investing activities during the three months ended March 31, 2022 of $13.3 million reflects capital expenditures.
Financing Activities — Net cash provided by financing activities for the three months ended March 31, 2023 of $25.6 million primarily reflects $22.5 million of dividends paid.
Net cash used by financing activities for the three months ended March 31, 2022 of $43.8 million primarily reflects $21.7 million of dividends paid, repayment of debt of $2.4 million, and repurchase of our outstanding common shares of $15.8 million.
Debt
As of March 31, 2023, our principal amount of debt totaled $2,215.5 million. Aggregate maturities of the principal amount of debt for the current year, next four years and thereafter, are as follows:
(In millions)
| 2023 | $1.4 |
| 2024 | 2.2 |
| 2025 | 652.2 |
| 2026 | 427.4 |
| 2027 | 0.4 |
| Thereafter | 1,131.9 |
| Aggregate maturities | $2,215.5 |
As of March 31, 2023, we were in compliance with all financial and restrictive covenants pertaining to our debt. For additional information regarding our debt, please see Note 9, Financing Arrangements to the accompanying condensed consolidated financial statements.
Derivatives and Hedging
We are exposed to market risks, such as changes in foreign currency exchange rates and interest rates. To manage the volatility related to these exposures we may enter into various derivative transactions. For additional information regarding our derivative instruments, please see Note 12, Derivatives and Hedging to the accompanying condensed consolidated financial statements.
Material Cash Requirements
We have future obligations under various contracts relating to debt and interest payments, derivative instruments, operating leases, pension and post-retirement benefit plans and purchase obligations. During the three months ended March 31, 2023, there were no material changes to these obligations as reported in our Annual Report on Form 10-K for the year ended December 31, 2022.
CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS
In this Quarterly Report on Form 10-Q, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historic or current facts. They use words such as "will," “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning in connection with any discussion of future operating or financial condition, performance and/or sales. In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and environmental liabilities; and financial results. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
- disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
- the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
- the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without limitation, any supply chain and logistics issues;
- changes in laws and regulations regarding plastics in jurisdictions where we conduct business;
- fluctuations in raw material prices, quality and supply, and in energy prices and supply;
- production outages or material costs associated with scheduled or unscheduled maintenance programs;
- unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
- an inability to raise or sustain prices for products or services;
- our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
- information systems failures and cyberattacks;
- amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions;
- our ability to achieve strategic objectives and successfully integrate acquisitions, including Avient Protective Materials (APM);
- other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation and any recessionary conditions; and
- other factors described in our Annual Report on Form 10-K for the year ended December 31, 2022 under Item 1A, “Risk Factors.”
We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law. You are advised, however, to consult any further disclosures we make on related subjects in our reports on Forms 10-Q, 8-K and 10-K filed with the Securities and Exchange Commission. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.
Market risk
As filed, 147 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to exposures to market risk as reported in our Annual Report on Form 10-K for the year ended December 31, 2022.
Controls and procedures
As filed, 951 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Disclosure controls and procedures
Avient’s management, under the supervision of and with the participation of its Chief Executive Officer and its Chief Financial Officer, has evaluated the effectiveness of the design and operation of Avient’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this Quarterly Report. Based upon this evaluation, Avient’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report, its disclosure controls and procedures were effective.
Changes in internal control over financial reporting
There were no changes in Avient’s internal control over financial reporting during the quarter ended March 31, 2023 that materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.
Risk factors
As filed, 395 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We face a number of risks that could adversely affect our business, results of operations, financial position or cash flows. A discussion of our risk factors can be found in Item 1A, Risk factors, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. During the first quarter ended March 31, 2023, there were no material changes to our previously disclosed risk factors.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-01 to 2023-03-31 | $845.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-01-01 to 2023-03-31 | $598.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-01-01 to 2023-03-31 | $247.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-01-01 to 2023-03-31 | $190.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-01-01 to 2023-03-31 | $57.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-01-01 to 2023-03-31 | $7.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-01 to 2023-03-31 | $19.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-01 to 2023-03-31 | $0.22 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-01 to 2023-03-31 | $0.22 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-03-31 | 91,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-01-01 to 2023-03-31 | −$22.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-01-01 to 2023-03-31 | $20.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2023-01-01 to 2023-03-31 | $22.5m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months2023-01-01 to 2023-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2023-03-31 | $1.56bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-31 | $6.11bn | us-gaap:Assets |
| Current liabilities | At period end2023-03-31 | $837.2m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2023-03-31 | $2.18bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-03-31 | $2.2m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-03-31 | $2.35bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-03-31 | 91,072,473 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001122976-23-000021. Last ingested by Listed: Nov 12, 2026, 17:37 ET. Listed shows no prices and gives no investment advice.